首页|通心络胶囊联合沙库巴曲缬沙坦对老年慢性心力衰竭患者的影响

通心络胶囊联合沙库巴曲缬沙坦对老年慢性心力衰竭患者的影响

扫码查看
目的:探讨通心络胶囊联合沙库巴曲缬沙坦对老年慢性心力衰竭(CHF)患者的影响。方法:选取2021年1月—2023 年 1 月厦门大学附属龙岩中医院收治的 80 例老年CHF患者。根据随机数表法将其分为对照组(n=39)及观察组(n=41)。两组均给予常规西药治疗,对照组给予沙库巴曲缬沙坦,观察组在对照组基础上给予通心络胶囊。比较两组临床疗效,治疗前及治疗 3 个月后心功能、氧化应激指标及不良反应。结果:观察组总有效率(95。12%)高于对照组(79。49%),差异有统计学意义(P<0。05)。治疗 3 个月后,两组左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)均降低,左心室射血分数(LVEF)升高,观察组LVEDD、LVESD均低于对照组,LVEF高于对照组,差异有统计学意义(P<0。05)。治疗 3 个月后,两组超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)水平均升高,观察组SOD、GSH-Px水平均高于对照组,差异有统计学意义(P<0。05)。两组不良反应发生率比较,差异无统计学意义(P>0。05)。结论:对老年CHF患者采用通心络胶囊联合沙库巴曲缬沙坦可有效提高其临床疗效、改善心功能、氧化应激指标,且安全性较好。
Effect of Tongxinluo Capsules Combined with Sacubitril Valsartan on Elderly Patients with Chronic Heart Failure
Objective:To investigate the effect of Tongxinluo Capsules combined with Sacubitril Valsartan on elderly patients with chronic heart failure(CHF).Method:A total of 80 elderly patients with CHF treated in Longyan Hospital of Traditional Chinese Medicine Affiliated to Xiamen University from January 2021 to January 2023 were selected.They were divided into control group(n=39)and observation group(n=41)according to random number table method.Both groups were given conventional western medicine treatment,the control group was given Sacubactril Valsartan,the observation group was given Tongxinluo Capsules on the basis of the control group.The clinical efficacy,cardiac function,oxidative stress index before treatment and after 3 months of treatment and adverse reactions were compared between the two groups.Result:The total effective rate of the observation group(95.12%)was higher than that of the control group(79.49%),and the difference was statistically significant(P<0.05).After 3 months of treatment,left ventricular end-diastolic diameter(LVEDD)and left ventricular end-systolic diameter(LVESD)in the two groups were decreased,left ventricular ejection fraction(LVEF)was increased,LVEDD and LVESD in the observation group were lower than those in the control group,and LVEF was higher than that in the control group,the differences were statistically significant(P<0.05).After 3 months of treatment,superoxide dismutase(SOD)and glutathione peroxidase(GSH-Px)levels in both groups were increased,and SOD and GSH-Px levels in observation group were higher than those in control group,the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Using Tongxinluo Capsules combined with Sacubactril Valsartan can effectively improve the clinical efficacy,cardiac function and oxidative stress indexes for elderly patients with CHF,with good safety.

Tongxinluo CapsulesSacubatrol ValsartanChronic heart failureOxidative stress

谢景毕、李文彬

展开 >

厦门大学附属龙岩中医院 福建 龙岩 364000

通心络胶囊 沙库巴曲缬沙坦 慢性心力衰竭 氧化应激

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(23)